A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug ...

Introduction People with intellectual disability face significant barriers to accessing genetic healthcare, including during ...

Protein microarrays labelled with fluorophores constitute a versatile platform for high-throughput analysis of protein interactions, expression levels and post-translational modifications. In a ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Curious about how to detect and characterize tumor-derived biomarkers from liquid biopsy samples? Genomics-based methods now provide access to more molecular data than ever before, delivering cancer ...

We have developed a novel microarray system based on three technologies: 1) molecular beacons designed to interact with DNA targets at room temperature (25–27°C), 2) tridimensional silk-based ...

bp = base pairs; CDR3 = complementarity determining region 3; MRD = minimal residual disease; RACE = rapid amplification of cDNA ends; V = variable. Altogether, these initial results suggest that ...

Background: The value of immunohistochemistry (IHC)-microarray analysis of pathological specimens in the management of patients is controversial, although preliminary data suggest potential benefit.